OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Cost Effectiveness of the First‐in‐Class ARNI (Sacubitril/Valsartan) for the Treatment of Essential Hypertension in a Chinese Setting
Xinyue Dong, Xiaoning He, Jing Wu
PharmacoEconomics (2022) Vol. 40, Iss. 12, pp. 1187-1205
Closed Access | Times Cited: 4
Xinyue Dong, Xiaoning He, Jing Wu
PharmacoEconomics (2022) Vol. 40, Iss. 12, pp. 1187-1205
Closed Access | Times Cited: 4
Showing 4 citing articles:
Cost-effectiveness of universal genetic screening for familial hypercholesterolemia in young adults aged 18–40 years in China
Rui Meng, Fenghao Shi, Baoming Zhang, et al.
BMC Medicine (2025) Vol. 23, Iss. 1
Open Access | Times Cited: 1
Rui Meng, Fenghao Shi, Baoming Zhang, et al.
BMC Medicine (2025) Vol. 23, Iss. 1
Open Access | Times Cited: 1
Economic evaluation of Erdafitinib as a second-line treatment for advanced metastatic urothelial carcinoma: real-world data from the USA and prospective analysis from China
Andong Li, Meiyu Wu, Ouyang Xie, et al.
Future Oncology (2025), pp. 1-9
Closed Access
Andong Li, Meiyu Wu, Ouyang Xie, et al.
Future Oncology (2025), pp. 1-9
Closed Access
Evaluating the Validation Process: Embracing Complexity and Transparency in Health Economic Modelling
Isaac Corro Ramos, Talitha Feenstra, Salah Ghabri, et al.
PharmacoEconomics (2024) Vol. 42, Iss. 7, pp. 715-719
Open Access | Times Cited: 2
Isaac Corro Ramos, Talitha Feenstra, Salah Ghabri, et al.
PharmacoEconomics (2024) Vol. 42, Iss. 7, pp. 715-719
Open Access | Times Cited: 2
Sacubitril/Valsartan for Heart Failure with Preserved Ejection Fraction: A Cost-Effectiveness Analysis from the Perspective of the Chinese Healthcare System
Zhe Wang, Yake Lou, Qi Wang, et al.
Clinical Drug Investigation (2023) Vol. 43, Iss. 4, pp. 265-275
Closed Access | Times Cited: 3
Zhe Wang, Yake Lou, Qi Wang, et al.
Clinical Drug Investigation (2023) Vol. 43, Iss. 4, pp. 265-275
Closed Access | Times Cited: 3
Progress in diagnosis and treatment of hypertension combined with left ventricular hypertrophy
Yongjin Han, Yanqiu Li, Wu Zhen, et al.
Annals of Medicine (2024) Vol. 56, Iss. 1
Open Access
Yongjin Han, Yanqiu Li, Wu Zhen, et al.
Annals of Medicine (2024) Vol. 56, Iss. 1
Open Access
